PortfoliosLab logoPortfoliosLab logo
FBT.L vs. BTEC.L
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

FBT.L vs. BTEC.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L) and iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (BTEC.L). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

FBT.L is traded in GBp, while BTEC.L is traded in USD. To make them comparable, the BTEC.L values have been converted to GBp using the latest available exchange rates.

Returns By Period

In the year-to-date period, FBT.L achieves a 17.27% return, which is significantly higher than BTEC.L's 13.97% return.


FBT.L

1D
-0.19%
1M
8.27%
6M
14.75%
YTD
17.27%
1Y
49.02%
3Y*
15.75%
5Y*
8.78%
10Y*

BTEC.L

1D
0.00%
1M
7.86%
6M
11.73%
YTD
13.97%
1Y
47.71%
3Y*
15.40%
5Y*
6.09%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

FBT.L vs. BTEC.L - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
FBT.L
First Trust NYSE Arca Biotechnology UCITS ETF Acc
17.27%17.28%6.52%-1.81%5.32%-2.57%7,473.50%
BTEC.L
iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
13.97%23.49%-0.33%0.91%-1.44%0.45%3.18%

Correlation

The correlation between FBT.L and BTEC.L is 0.84, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.84

Correlation (3Y)
Calculated over the trailing 3-year period

0.83

Correlation (5Y)
Calculated over the trailing 5-year period

0.86

Correlation (All Time)
Calculated using the full available price history since May 20, 2020

0.86

The correlation between FBT.L and BTEC.L has been stable across timeframes, ranging from 0.83 to 0.86 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FBT.L vs. BTEC.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FBT.L
FBT.L Risk / Return Rank: 8282
Overall Rank
FBT.L Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
FBT.L Sortino Ratio Rank: 8989
Sortino Ratio Rank
FBT.L Omega Ratio Rank: 8484
Omega Ratio Rank
FBT.L Calmar Ratio Rank: 8282
Calmar Ratio Rank
FBT.L Martin Ratio Rank: 6666
Martin Ratio Rank

BTEC.L
BTEC.L Risk / Return Rank: 9090
Overall Rank
BTEC.L Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
BTEC.L Sortino Ratio Rank: 8989
Sortino Ratio Rank
BTEC.L Omega Ratio Rank: 8282
Omega Ratio Rank
BTEC.L Calmar Ratio Rank: 9595
Calmar Ratio Rank
BTEC.L Martin Ratio Rank: 9393
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FBT.L vs. BTEC.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L) and iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (BTEC.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FBT.LBTEC.LDifference
Sharpe ratioReturn per unit of total volatility

+0.03

Sortino ratioReturn per unit of downside risk

+0.18

Omega ratioGain probability vs. loss probability

1.39

1.37

+0.02

Calmar ratioReturn relative to maximum drawdown

3.53

6.45

-2.92

Martin ratioReturn relative to average drawdown

9.57

18.57

-8.99

FBT.L vs. BTEC.L - Sharpe Ratio Comparison

The current FBT.L Sharpe Ratio is 2.34, which is comparable to the BTEC.L Sharpe Ratio of 2.31. The chart below compares the historical Sharpe Ratios of FBT.L and BTEC.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

FBT.L vs. BTEC.L - Drawdown Comparison

The maximum FBT.L drawdown since its inception was -30.39%, roughly equal to the maximum BTEC.L drawdown of -31.02%. Use the drawdown chart below to compare losses from any high point for FBT.L and BTEC.L.


Loading charts...

Drawdown Indicators


FBT.LBTEC.LDifference

Max Drawdown

Largest peak-to-trough decline

-30.39%

-31.02%

+0.63%

Max Drawdown (1Y)

Largest decline over 1 year

-13.81%

-7.31%

-6.50%

Max Drawdown (3Y)

Largest decline over 3 years

-24.59%

-26.37%

+1.78%

Max Drawdown (5Y)

Largest decline over 5 years

-24.59%

-31.02%

+6.43%

Current Drawdown

Current decline from peak

-4.56%

-5.72%

+1.16%

Average Drawdown

Average peak-to-trough decline

-13.21%

-9.99%

-3.22%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.11%

2.54%

+2.57%

Volatility

FBT.L vs. BTEC.L - Volatility Comparison

First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L) has a higher volatility of 6.25% compared to iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (BTEC.L) at 5.91%. This indicates that FBT.L's price experiences larger fluctuations and is considered to be riskier than BTEC.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FBT.LBTEC.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.25%

5.91%

+0.34%

Volatility (6M)

Calculated over the trailing 6-month period

15.78%

15.31%

+0.47%

Volatility (1Y)

Calculated over the trailing 1-year period

20.92%

20.42%

+0.50%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

23.80%

20.98%

+2.82%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

3,210.80%

22.30%

+3,188.50%

FBT.L vs. BTEC.L - Expense Ratio Comparison

FBT.L has a 0.60% expense ratio, which is higher than BTEC.L's 0.35% expense ratio.


Dividends

FBT.L vs. BTEC.L - Dividend Comparison

Neither FBT.L nor BTEC.L has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


FBT.L and BTEC.L have a correlation of 0.84, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, BTEC.L is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.

BTEC.L is cheaper with a 0.35% expense ratio, compared with 0.60% for FBT.L.

FBT.L tracks NASDAQ Biotechnology TR USD, while BTEC.L tracks NASDAQ Biotechnology NET Index. They also come from different issuers: First Trust and iShares. Their fees differ too: 0.60% for FBT.L and 0.35% for BTEC.L.

Portfolio Optimizer

Find the right allocation for FBT.L and BTEC.L

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer